Zimmer Biomet Director Noor Jehanzeb Buys 10,076 RSUs, Betting on Long‑Term Growth Amid Dividend Boost and Bone‑Growth Expansion News Flash
Insider buying at Zimmer Biomet shows long‑term confidence: Noor Jehanzeb’s 10k RSU purchase signals bullish outlook and potential growth in bone‑growth stimulation, plus a fresh dividend boost for investors.
4 minutes to read